Adding Memantine to Rivastigmine Therapy in Patients With Mild-to-Moderate Alzheimer's Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adding Memantine to Rivastigmine Therapy in Patients With Mild-to-Moderate Alzheimer's Disease

Published:2006-10-16 Issue:05 Volume:08 Page:258-263
ISSN:1523-5998
Container-title:The Primary Care Companion to The Journal of Clinical Psychiatry
language:
Short-container-title:Prim. Care Companion J. Clin. Psychiatry

Author:

Riepe Matthias W.,Adler Georg,Ibach Bernd,Weinkauf Birgit,Gunay Ibrahim,Tracik Ferenc

Publisher

Physicians Postgraduate Press, Inc

Subject

Psychiatry and Mental health

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress and Development of Carbazole Scaffold Based as Potential Anti- Alzheimer Agents Using MTDL Approach;Letters in Drug Design & Discovery;2022-12

2. Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives;Frontiers in Neuroscience;2022-08-04

3. Evaluation of rivastigmine in Alzheimer's disease;Neurodegenerative Disease Management;2021-02

4. ATP Controls the Aggregation of Aβ16–22 Peptides;The Journal of Physical Chemistry B;2019-12-12

5. Current Updates on the Regulation of Beta-Secretase Movement as a Potential Restorative Focus for Management of Alzheimer's Disease;Protein & Peptide Letters;2019-09-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP